References
- Rice-Evans C, Miller NJ. Structure-antioxidant activity relationships of flavonoids and isoflavonoids. pp. 199-219. In: Flavonoids in Health and Disease, Rice-Evans C and Parker L (ed). Marcel Dekker, Inc., New York, USA (1998)
- Hertog MGL, Hollman PCH, van de Putte B. Contents of potentially anticarcinogenic flavonoids in tea infusions, wines, and fruit juices. J. Agric. Food Chem. 41: 1242-1246 (1993) https://doi.org/10.1021/jf00032a015
- Picinelli A, Suarez B, Mangas JJ. Analysis of polyphenols in apple products. Z. Lebensm. Unters. Forsch. A 204: 48-51 (1997) https://doi.org/10.1007/s002170050035
- Price KR, Rhodes MJC. Analysis of the major flavonol glycosides present in four varieties of onion (Allium cepa) and changes in composition resulting from autolysis. J. Sci. Food Agric. 74: 331-339 (1997) https://doi.org/10.1002/(SICI)1097-0010(199707)74:3<331::AID-JSFA806>3.0.CO;2-C
- Chen YC, Shen SC, Chow JM, Ko CH, Tseng SW. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int. J. Oncol. 25: 661-670 (2004)
- Edenharder R and Grunhage D. Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyhydroperoxide or cumene hydro peroxide in Salmonella typhimurium TA102. Mut. Res. 9: 1-18 (2003)
- Pinot F, el Yaagoubi A, Christie P, Dinh-Xuan AT, Polla BS. Induction of stress proteins by tobacco smoke in human monocytes: modulation by antioxidants. Cell Stress Chaperone 2: 156-161 (1997) https://doi.org/10.1379/1466-1268(1997)002<0156:IOSPBT>2.3.CO;2
- Psotova J, Chlopcikova S, Miketova P, Hrbac J, Simanek V. Chemoprotective effects of plant phenolics against anthracyclineinduced toxicity on rat cardiomyocytes: Part III. Apigenin, baicalein, kaempherol, luteolin and quercetin. Phytother. Res. 18: 516-521 (2004) https://doi.org/10.1002/ptr.1462
- Daniel RS, Devi KS, Augusti KT, Sudhakaran Nair CR. Mechanism of actionof antiatherogenic and related effects of Ficus bengalensis Linn. flavonoids in experimental animals. Indian J. Exp. Biol. 41: 296-303 (2003)
- Duarte J, Perez-Palencia R, Vargas F, Ocete MA, Perez-Vizcaino F, Zarzuelo A, Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 133: 117-124 (2001) https://doi.org/10.1038/sj.bjp.0704064
- Soloviev A, Stefanov A, Parshikov A, Khromov A, Moibenko A, Kvotchina L, Balavoine G, Geletii Y. Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposome. Cardiovasc. Toxicol. 2: 129-139 (2002) https://doi.org/10.1385/CT:2:2:129
- Kahraman A, Inal ME. Protective effects of quercetin on ultraviolet A light-induced oxidative stress in the blood of rat. J. Appl. Toxicol. 22: 303-309 (2002) https://doi.org/10.1002/jat.863
- Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozotocin-induced diabetic rats. Com. Biochem. Physiol. C 135: 357-364 (2003) https://doi.org/10.1016/S1095-6433(03)00090-4
- Mahesh T, Menon VP. Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats. Phytother. Res. 18: 123-127 (2004) https://doi.org/10.1002/ptr.1374
- De S, Chakraborty RN, Ghosh S, Sengupta A, Das S. Comparative evaluation of cancer chemopreventive efficacy of alpha-tocopherol and quercetin in a murine model. J. Exp. Clin. Cancer Res. 23: 251-258 (2004)
- Naidu PS, Kunkami SK. Quercetin, a bioflavonoid, reverse haloperidol-induced catalepsy. Methods Find. Exp. Clin. Pharmacol. 26: 323-326 (2004) https://doi.org/10.1358/mf.2004.26.5.831321
- Janbaz KH, Saeed SA, Gilani AH. Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents. Phytomedicine 11: 424-430 (2004) https://doi.org/10.1016/j.phymed.2003.05.002
- Erlund I, Kosonen T, Alfthan G, Maenpaa, Perttunen K, Kenraali J, Aro A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. 56: 545-553 (2000) https://doi.org/10.1007/s002280000197
- Graefe EU, Derendorf H, Veit M. Pharamcokinetic and bioavailability of the flavol quercetin in humans. Int. J. Clin. Pharmacol. Therapy 37: 219-233 (1999)
- Ader P, Wessmann A, Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Rad. Biol. Med. 28: 1056-1067 (2000) https://doi.org/10.1016/S0891-5849(00)00195-7
- Khaled KA, El-Sayed YM, Al-Hadiya BM. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev. Ind. Pharmcol. 29: 397-403 (2003) https://doi.org/10.1081/DDC-120018375
-
Morrice PC, Wood SG, Duthie GG. High-performance liquid chromatographic determination of quercetin and isorhamnetin in rat tissues using
$\beta$ -glucuronidase and acid hydrolysis. J. Chromatogr. B 738: 413-417 (2000) https://doi.org/10.1016/S0378-4347(99)00520-4 - Piskula MK, Terao J. Quercetin solubility affects its accumulation in rats after oral administration. J. Agric. Food. Chem. 46: 4313-4317 (1998) https://doi.org/10.1021/jf980117v
- Wollenber E. Flavones and flavonols. pp. 189-259. In: The Flavonoids: Advances in Research. Harbone TJ and Marby TJ (ed). Chapman and Hall, London, UK (1982)
- Hollman PCH, Bijsman MNCP, van Gameren Y, Cnossen EJP, de Vries JHM, Katan MB. The sugar moeity is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Rad. Res. 31: 569-573 (1999) https://doi.org/10.1080/10715769900301141
- Day AJ, Dupont MS, Ridley S, Rhodes M, Rhodes MJ, Morgan MR. Deglycosylation of flavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 436: 71-75 (1998) https://doi.org/10.1016/S0014-5793(98)01101-6
- Manach C, Texier O, Morand C, Crespy V, Regerat F, Dcrnigne C, Remesy C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FASEB Lett. 423: 331-336 (1998)
- Manach C, Morand C, Crespy V, Demigne C, Texier O, Regerat F, Remesy C. Comparison of the bioavailability of quercetin and catechin in rats. Free Rad. Biol. Med. 27: 1259-1266 (1999) https://doi.org/10.1016/S0891-5849(99)00159-8
- Hallman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy isolectomy volunteers. Am. J. Clin. Nutr. 62: 1276-1282 (1995)
- Hallman PCH, van Trijp JMP, Mengelers MJB, de Vries JHM, Katan MB. Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett. 114: 139-140 (1997) https://doi.org/10.1016/S0304-3835(97)04644-2
- Hertog MGL, Katan MB. Quercetin in foods, cardiovascular disease, and cancer. pp. 199-219. In: Flavonoids in Health and Disease. Rice-Evans C and Parker L (ed). Marcel Dekker, Inc., New York, USA (1998)
- Sesink ALA, O'Leary KA, Hollman PCH. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4'-glucoside. J. Nutr. 131: 1938-1941 (2001)
- Meng X, Maliakal P, Lu H, Lee MJ, Yang CS. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after injestion of pure compounds and grape juice. J. Agric. Food Chem. 52: 935-942 (2004) https://doi.org/10.1021/jf030582e